Editorial - Neuromonitoring: The Concept of Targeted Therapy Revisited
The Open Neurosurgery Journal · 2010
DOI: 10.2174/1876529701003010064 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Open Neurosurgery Journal, 2010. Verfasst von Jean Francois Soustiel.
Abstract (Originalsprache)
Xenon/CT provides quantitative CBF data that has a proven record of being both safe and prognostic for decision making.The technique itself has been extensively validated.Modern equipment has allowed for integration of the data into immediate bedside decision-making with the use of a portable head CT scanner and improved data processing.The use of xenon/CT in decision making in traumatic brain injury may have a high utility in determining whether a specific treatment-whether it is hyperventilation, induced hypertension, or other intervention-is in fact helpful to the individual patient.This can allow for decision making based on an individual patient's physiology rather than generalized guidelines which may, in some cases, even be harmful.
Zitieren
APA
Soustiel, J. F. (2010). Editorial - Neuromonitoring: The Concept of Targeted Therapy Revisited. The Open Neurosurgery Journal. https://doi.org/10.2174/1876529701003010064
Vancouver
Soustiel JF. Editorial - Neuromonitoring: The Concept of Targeted Therapy Revisited. The Open Neurosurgery Journal. 2010. doi:10.2174/1876529701003010064
BibTeX
@article{Soustiel2010,
author = {Soustiel, Jean Francois},
title = {Editorial - Neuromonitoring: The Concept of Targeted Therapy Revisited},
journal = {The Open Neurosurgery Journal},
year = {2010},
doi = {10.2174/1876529701003010064}
}
EUVIMED